piperacetazine has been researched along with Rhabdomyosarcoma 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, FG; Chou, HC; Deniz, E; Keller, C; Khan, J; Kouassi-Brou, M; Molotkova, A; Nakazawa, K; Shaw, T; Song, YK; Tiwari, PB; Toretsky, JA; Üren, A; Wei, JS; Wen, X | 1 |
1 other study(ies) available for piperacetazine and Rhabdomyosarcoma 2
| Article | Year |
|---|---|
Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.
Topics: Forkhead Box Protein O1; Humans; Paired Box Transcription Factors; PAX3 Transcription Factor; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Translocation, Genetic | 2023 |